The role of everolimus in metastatic breast cancer and possibilities of moving forward-a narrative review.

The most promising research directions seem to be further investigations for useable predictive biomarkers, for combinations with other targeted drugs (even in a triple combination) and for the feasibility of pharmacologically guided dosing method.